{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:23:28Z","timestamp":1792783408898,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Viatris","id":[{"id":"https:\/\/ror.org\/01g1gvr46","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pain Ther"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s40122-026-00879-y","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:27:07Z","timestamp":1786976827000},"page":"1623-1635","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Phenotypic Factors and Celecoxib Efficacy in Knee OA: A Post\u2011hoc Pooled Analysis of Two Randomized, Double\u2011Blind, Placebo\u2011Controlled Trials"],"prefix":"10.1007","volume":"15","author":[{"given":"Jean-Yves","family":"Reginster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Fuggle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egbert","family":"Biesheuvel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivasan","family":"Venugopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar Suresh","family":"Kumbhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella Maria Rita","family":"Chiaese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Choy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"879_CR1","doi-asserted-by":"crossref","unstructured":"GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204\u201322.","DOI":"10.1016\/S0140-6736(20)30925-9"},{"key":"879_CR2","unstructured":"World Health Organization. Osteoarthritis [Internet]. Geneva: World Health Organization; 2023 Jul 14 [cited 2026 Jul 2]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/osteoarthritis"},{"issue":"6","key":"879_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12061262","volume":"12","author":"V Mocanu","year":"2024","unstructured":"Mocanu V, Timofte DV, Zar\u0103-D\u0103nceanu C-M, et al. Obesity, metabolic syndrome, and osteoarthritis require integrative understanding and management. Biomedicines (Basel). 2024;12(6):1262.","journal-title":"Biomedicines (Basel)"},{"issue":"2","key":"879_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ocarto.2025.100614","volume":"7","author":"S Huang","year":"2025","unstructured":"Huang S, Chen J, Zhang H, et al. Inflammatory mechanisms underlying metabolic syndrome-associated and potential treatments. Osteoarthr Cartil Open. 2025;7(2):100614.","journal-title":"Osteoarthr Cartil Open."},{"issue":"14","key":"879_CR5","doi-asserted-by":"publisher","first-page":"3178","DOI":"10.3390\/jcm10143178","volume":"10","author":"M Tschon","year":"2021","unstructured":"Tschon M, Contartese D, Pagani S, et al. Gender and sex are key determinants in osteoarthritis not only confounding variables. A systematic review of clinical data. J Clin Med. 2021;10(14):3178.","journal-title":"J Clin Med."},{"issue":"4","key":"879_CR6","doi-asserted-by":"publisher","first-page":"601","DOI":"10.2217\/WHE.10.38","volume":"6","author":"JE Stevens-Lapsley","year":"2010","unstructured":"Stevens-Lapsley JE, Kohrt WM. Osteoarthritis in women: effects of estrogen, obesity and physical activity. Women Health (Lond). 2010;6(4):601\u201315.","journal-title":"Women Health (Lond)"},{"issue":"5","key":"879_CR7","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jpain.2008.12.001","volume":"10","author":"RB Fillingim","year":"2009","unstructured":"Fillingim RB, King CD, Ribeiro-Dasilva MC, et al. Sex, gender, and pain: a review of recent clinical and experimental findings. J Pain. 2009;10(5):447\u201385.","journal-title":"J Pain"},{"key":"879_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.copsyc.2025.102006","volume":"63","author":"E Keogh","year":"2025","unstructured":"Keogh E. Sex, gender, and pain: evidence and knowledge gaps. Curr Opin Psychol. 2025;63:102006.","journal-title":"Curr Opin Psychol."},{"key":"879_CR9","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6648437","author":"T-M Borg","year":"2021","unstructured":"Borg T-M, Heidari N, Noorani A, et al. Gender-specific response in pain and function to biologic treatment of knee osteoarthritis: a gender-bias-mitigated, observational, intention-to-treat study at two years. Stem Cells Int. 2021. https:\/\/doi.org\/10.1155\/2021\/6648437.","journal-title":"Stem Cells Int"},{"issue":"7","key":"879_CR10","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/obr.12173","volume":"15","author":"H Bliddal","year":"2014","unstructured":"Bliddal H, Leeds AR, Christensen R. Osteoarthritis, obesity and weight loss: evidence, hypotheses and horizons\u2014a scoping review. Obes Rev. 2014;15(7):578\u201386.","journal-title":"Obes Rev"},{"key":"879_CR11","doi-asserted-by":"publisher","first-page":"d1165","DOI":"10.1136\/bmj.d1165","volume":"342","author":"E N\u00fcesch","year":"2011","unstructured":"N\u00fcesch E, Dieppe P, Reichenbach S, et al. All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study. BMJ. 2011;342:d1165.","journal-title":"BMJ"},{"key":"879_CR12","unstructured":"Osteoarthritis Research Society International (OARSI). Osteoarthritis: a serious disease. Submitted to the U.S. Food and Drug Administration. Mount Laurel (NJ): OARSI; 2016 Dec 1 [cited 2026 Jul 9]. Available from: https:\/\/oarsi.org\/sites\/oarsi\/files\/docs\/2016\/oarsi_white_paper_oa_serious_disease_121416_1.pdf"},{"key":"879_CR13","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.2147\/JPR.S94650","volume":"11","author":"S Packiasabapathy","year":"2018","unstructured":"Packiasabapathy S, Sadhasivam S. Gender, genetics, and analgesia: understanding the differences in response to pain relief. J Pain Res. 2018;11:2729\u201339.","journal-title":"J Pain Res"},{"issue":"2","key":"879_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/00124743-200004000-00002","volume":"6","author":"GW Williams","year":"2000","unstructured":"Williams GW, Ettlinger RE, Ruderman EM, et al. Treatment of osteoarthritis with a once-daily dosing regimen of celecoxib: a randomized, controlled trial. J Clin Rheumatol. 2000;6(2):65\u201374.","journal-title":"J Clin Rheumatol."},{"issue":"2","key":"879_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0149-2918(01)80004-7","volume":"23","author":"GW Williams","year":"2001","unstructured":"Williams GW, Hubbard RC, Yu SS, et al. Comparison of once-daily and twice-daily administration of celecoxib for the treatment of osteoarthritis of the knee. Clin Ther. 2001;23(2):213\u201327.","journal-title":"Clin Ther"},{"issue":"1","key":"879_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s40520-025-03302-2","volume":"38","author":"E Choy","year":"2026","unstructured":"Choy E, Fuggle N, Biesheuvel E, et al. Different dosing regimens for chronic knee osteoarthritis (KOA) pain management: a pooled analysis on celecoxib. Aging Clin Exp Res. 2026;38(1):55.","journal-title":"Aging Clin Exp Res"},{"issue":"6","key":"879_CR17","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1080\/10543406.2013.834911","volume":"23","author":"JR Carpenter","year":"2013","unstructured":"Carpenter JR, Roger JH, Kenward MG. Analysis of longitudinal trials with protocol deviation: a framework for relevant, accessible assumptions, and inference via multiple imputation. J Biopharm Stat. 2013;23(6):1352\u201371.","journal-title":"J Biopharm Stat"},{"issue":"12","key":"879_CR18","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/nrn3360","volume":"13","author":"JS Mogil","year":"2012","unstructured":"Mogil JS. Sex differences in pain and pain inhibition: multiple explanations of a controversial phenomenon. Nat Rev Neurosci. 2012;13(12):859\u201366.","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"879_CR19","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1136\/ard-2023-225041","volume":"83","author":"T Moseng","year":"2023","unstructured":"Moseng T, Vliet Vlieland TPM, Battista S, et al. EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis: 2023 update. Ann Rheum Dis. 2023;83(6):730\u201340.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"879_CR20","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.joca.2019.06.011","volume":"27","author":"RR Bannuru","year":"2019","unstructured":"Bannuru RR, Osani MC, Vaysbrot EE, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019;27(11):1578\u201389.","journal-title":"Osteoarthritis Cartilage"},{"issue":"3","key":"879_CR21","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.semarthrit.2019.04.008","volume":"49","author":"O Bruy\u00e8re","year":"2019","unstructured":"Bruy\u00e8re O, Honvo G, Veronese N, et al. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin Arthritis Rheum. 2019;49(3):337\u201350.","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"879_CR22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41584-020-00523-9","volume":"17","author":"NK Arden","year":"2021","unstructured":"Arden NK, Perry TA, Bannuru RR, et al. Non-surgical management of knee osteoarthritis: comparison of ESCEO and OARSI 2019 guidelines. Nat Rev Rheumatol. 2021;17(1):59\u201366.","journal-title":"Nat Rev Rheumatol."},{"issue":"26","key":"879_CR23","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1056\/NEJMoa1611593","volume":"375","author":"SE Nissen","year":"2016","unstructured":"Nissen SE, Yeomans ND, Solomon DH, et al. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med. 2016;375(26):2519\u201329.","journal-title":"N Engl J Med."}],"container-title":["Pain and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-026-00879-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40122-026-00879-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-026-00879-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:29:59Z","timestamp":1790677799000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40122-026-00879-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["879"],"URL":"https:\/\/doi.org\/10.1007\/s40122-026-00879-y","relation":{},"ISSN":["2193-8237","2193-651X"],"issn-type":[{"value":"2193-8237","type":"print"},{"value":"2193-651X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"assertion":[{"value":"4 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Jean-Yves Reginster has received support and\/or a paid consultant and\/or received payment or honoraria and\/or received support for attending meetings and\/or travel and\/or Participation on Advisory Board of Viatris. Nicholas Fuggle received payment or honoraria from Viatris, Amgen, and UCB. Egbert Biesheuvel and Chris Walker are employees and own stocks in Viatris. Srinivasan Venugopal, Sagar Suresh Kumbhar, and Raffaella Maria Rita Chiaese are employees of Viatris. Ernest Choy has received support and\/or received grants and\/or a paid consultant and\/or received payment or honoraria and\/or is an editor of and\/or owns stocks and\/or recipient of miscellaneous services from Viatris, Pfizer, BioCancer, Sanofi, Abbvie, Biogen, Fresenius Kabi, Editor of Rheumatology (Oxford), and Inmedix","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No primary human or animal data were collected for this post hoc analysis. The study represents a pooled evaluation of previously published randomized controlled trials (Williams 2000; Williams 2001). No additional data collection was undertaken; only anonymized secondary datasets were analyzed. This post hoc pooled analysis was conducted using anonymized data from two previously completed randomized controlled trials. The original studies received approval from the relevant institutional review boards or ethics committees, all participants provided written informed consent prior to study participation, and the studies were conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}